KORU Medical Systems (NASDAQ:KRMD) Given “Neutral” Rating at Piper Sandler

KORU Medical Systems (NASDAQ:KRMD)‘s stock had its “neutral” rating reaffirmed by investment analysts at Piper Sandler in a research note issued on Friday,Benzinga reports. They presently have a $4.50 price target on the stock. Piper Sandler’s price target would suggest a potential downside of 5.26% from the company’s current price.

Other equities analysts have also issued research reports about the company. Canaccord Genuity Group lifted their price target on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Craig Hallum lifted their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, January 17th. Finally, Lake Street Capital upped their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $4.70.

KORU Medical Systems Stock Up 2.2 %

Shares of NASDAQ:KRMD opened at $4.75 on Friday. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01. The stock has a fifty day simple moving average of $4.12 and a two-hundred day simple moving average of $3.21. KORU Medical Systems has a 12-month low of $2.01 and a 12-month high of $5.05. The stock has a market capitalization of $217.74 million, a price-to-earnings ratio of -19.00 and a beta of 0.45.

Institutional Investors Weigh In On KORU Medical Systems

Several large investors have recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in shares of KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after acquiring an additional 28,323 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after purchasing an additional 26,860 shares during the last quarter. Calamos Advisors LLC bought a new stake in KORU Medical Systems in the 4th quarter worth approximately $250,000. XTX Topco Ltd purchased a new stake in KORU Medical Systems during the 3rd quarter valued at $34,000. Finally, Empire Financial Management Company LLC bought a new position in shares of KORU Medical Systems during the 3rd quarter valued at $259,000. 58.60% of the stock is currently owned by institutional investors.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.